Fernando Gomes Romeiro
CV Lattes
GoogleMyCitations
ResearcherID
Universidade Estadual Paulista (UNESP). Campus de Botucatu. Faculdade de Medicina (FMB) (Institutional affiliation for the last research proposal) Birthplace: Brazil
Graduate at Medicine from Universidade Estadual Paulista Júlio de Mesquita Filho. Has experience in gastroenterology and hepatology and has Doctorade in Internal Medicine Phisiopathology. Works as Post-Graduation professor in the course of Internal Medicine Phisiopathology and as Graduation professor at UNESP. Has especialist title of Gastroenterologist and is a member of Brazilian Society of Hepatology. Participates on CPFig group - a group of research involved in Clinical and Phisiopathology studies on the Liver Diseases. (Source: Lattes Curriculum)
- Objective tumoral response, safety profile and survival rates of patients with liver cirrhosis and hepatocellular carcinoma of intermediate stage submitted to radioembolization with 131I-Lipiodol versus transarterial Chemoembolization, AP.R
Abstract
The incidence and prevalence of hepatocellular carcinoma (HCC) is growing worldwide, leading to high mortality rates. The disease occurs mainly in cirrhotic patients, and the cure can be reached only when it is diagnosed early or when the tumor is submitted to adjuvant therapies to reduce the tumor size, being the transarterial chemoembolization (TACE) the most used approach to achieve ...
- Risedronate for osteoporosis treatment in patients with liver cirrhosis and esophageal varices: assessment on safety profile and bone mass, AP.R
Abstract
Osteoporosis is the only complication of liver cirrhosis that persists even after liver transplantation. It is a common complication among cirrhotic patients, increasing the risk of fractures and thus affecting morbidity and mortality rates. Early diagnosis and proper treatment are needed to avoid fractures and disability. The treatment requires nutritional supplementation of calcium an...
- Effect of isolated branched chain amino acids in the serum pH and cerebral blood flow of cirrhotic patients: a randomized, double blind controlled trial, AP.R
Abstract
Hepatic encephalopathy (HE) is a serious complication of cirrhosis. The swelling of astrocytes, caused by the conversion of ammonia to glutamine into the brain, is a leading cause of persistent HE, impairing the cerebral blood flow. It has been shown that alkalemia is a trigger for HE, but few studies have evaluated the serum pH in these patients.The use of branched chain amino acids (B...
- Corticoids in severe alcoholic hepatitis in patients with cirrhosis and contraindications to receiving corticoids: a retrospective study of patients admitted in a reference hospital, BP.IC
Abstract
Alcoholic hepatitis (AH) is a highly prevalent disease in patients addicted to alcohol. AH mortality is high, ranging from 30-50% during the first 28 days of hospitalization. The signs and symptoms are varied and not very specific because many of them can be already seen in cirrhotic patients. Laboratory tests are essential for grading AH severity, thus indicating a liver biopsy only if...
- Screening of transthyretin-related hereditary amyloidosis among patients with disautonomy diagnosed by the head-up tilt table test, BP.IC
Abstract
Transthyretin familial amyloid polyneuropathy (TTR-FAP) is an inherited debilitating neurodegenerative disease that is irreversible and potentially fatal. Unfortunately, the disease is often diagnosed too late, years after its first manifestations, especially when the patient is the first confirmed case in the family, causing sensorimotor symptoms and progressive autonomic neuropathy. T...
- Endoscopic and hematimetric evaluation on risedronate safety profile among patients with liver cirrhosis and esophageal varices, BP.IC
Abstract
Liver cirrhosis is a relevant illness regarding worldwide morbidity and mortality and most patients have esophageal varices. Many studies have shown that osteoporosis is the only cirrhosis complication that keeps worsening after liver transplantation. Thus, the only way to avoid fractures due to bone loss is to combine early diagnosis and proper treatment, which is composed by calcium a...
- Bone changes in patients with liver cirrhosis treated for osteoporosis and osteopenia, BP.DR
Abstract
Introduction: Patients with liver cirrhosis have bone loss generated by various mechanisms, such as low intake of nutrients and lack of physical activity. At the same time, the bone treatment is often avoided in this population, particularly in advanced cirrhosis, due to the presence of esophageal varices. Objectives: To evaluate whether patients with cirrhosis and osteoporosis would be...
- Transarterial chemoembolization alone or associated to sorafenib for patients with hepatocellular carcinoma and hepatic cirrhosis: retrospective analysis, BP.IC
Abstract
Hepatocellular carcinoma (HCC) is the most common tumor originated in the liver. It is the 5th most common type of malignancy, and the 3rd largest cause of death from cancer. During the last two decades, HCC incidence has grown, and it is estimated that the prevalence continue to rise due to the increase of chronic liver diseases such as chronic viral hepatitis, alcohol consumption and ...
| 1 / 1 | Ongoing research grants |
| 2 / 2 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 4 / 3 | Completed scholarships in Brazil |
| 9 / 8 | All research grants and scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 4 |
| Citations | 24 |
| Cit./Article | 6.0 |
| Data from Web of Science | |
AMARAL SANTOS, LIVIA ALVES; ROMEIRO, FERNANDO GOMES. Diagnosis and Management of Cirrhosis-Related Osteoporosis. BIOMED RESEARCH INTERNATIONAL, 2016. Web of Science Citations: 7.
ROMEIRO, F. G.; CORÁ, L. A.; ANDREIS, U. DE; AMÉRICO, M. F.; OLIVEIRA, R. B.; BAFFA, O.; MIRANDA, J. R. A.. A novel biomagnetic approach to study caecocolonic motility in humans. Neurogastroenterology and Motility, v. 18, n. 12, p. 1078-1083, Dec. 2006.
AUGUSTI, L.; FRANZONI, L. C.; SANTOS, L. A. A.; LIMA, T. B.; IETSUGU, M. V.; KOGA, K. H.; MORIGUCHI, S. M.; BETTING, L. E.; CARAMORI, C. A.; SILVA, G. F.; et al. Lower values of handgrip strength and adductor pollicis muscle thickness are associated with hepatic encephalopathy manifestations in cirrhotic patients. METABOLIC BRAIN DISEASE, v. 31, n. 4, p. 909-915, AUG 2016. Web of Science Citations: 6.
ROMEIRO, FERNANDO GOMES; AUGUSTI, LAIS. Nutritional assessment in cirrhotic patients with hepatic encephalopathy. WORLD JOURNAL OF HEPATOLOGY, v. 7, n. 30, p. 2940-2954, DEC 28 2015. Web of Science Citations: 10.
ROMEIRO, FERNANDO GOMES; IETSUGU, MARJORIE DO VAL; FRANZONI, LETICIA DE CAMPOS; AUGUSTI, LAIS; ALVAREZ, MATHEUS; AMARAL SANTOS, LIVIA ALVES; LIMA, TALLES BAZEI; KOGA, KATIA HIROMOTO; MORIGUCHI, SONIA MARTA; CARAMORI, CARLOS ANTONIO; et al. Which of the branched-chain amino acids increases cerebral blood flow in hepatic encephalopathy? A double-blind randomized trial. NEUROIMAGE-CLINICAL, v. 19, p. 302-310, 2018. Web of Science Citations: 1.
(References retrieved automatically from State of São Paulo Research Institutions)
SANTOS, Lívia Alves Amaral. Resposta ao tratamento da osteoporose e osteopenia em portadores de cirrose hepática. 2019. Tese (Doutorado) – . Universidade Estadual Paulista "Júlio de Mesquita Filho" Faculdade de Medicina.